- Article
Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction
- Wei-Ting Chang,
- Yu-Wen Lin,
- Chin-Yu Chen,
- Zhih-Cherng Chen,
- Jhih-Yuan Shih,
- Chia-Ching Wu,
- Chwan-Yau Luo and
- Ping-Yen Liu
Mitral regurgitation (MR), the disruption of the mitral valve, contributes to heart failure (HF). Under conditions of volume overload, excess mineralocorticoids promote cardiac fibrosis. The mineralocorticoid receptor antagonist spironolactone is a p...

